市场调查报告书
商品编码
1410763
关节内粘稠补充疗法的全球市场 - 市场规模(各市场区隔),占有率,法规,偿付,治疗,预测(~2033年)Viscosupplementation Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
本报告提供全球关节内粘稠补充疗法市场相关调查分析,提供各市场区隔的市场规模,市场趋势,竞争情形,COVID-19影响等资讯。
市场模式的主要内容如下列。
已上市的关节内粘稠补充疗法设备与不断变化的竞争格局
世界,地区,国家层级的市场固有考察
透过掌握包含医疗制度概要的真实整体状况来促进对市场的认识。此外在打入市场部门更提供关于给付原则及法规情势之资讯,使您能够更深入地研究市场动态。
对象企业
Viscosupplementation Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Orthopedic Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on the Viscosupplementation market for the year 2020 and beyond.
Viscosupplementation is a minimally invasive procedure where hyaluronic acid (an active compound in synovial fluid) is injected into the joints. The procedure is majorly carried out in the knee, followed by the hip, shoulder, ankle, and other joints.
Viscosupplementation treatment regimens have been divided into 1-injection, 3-injection, and 5-injection regimens with 3 and 5-injection treatments showing major effects in pain relief. However, for the past few there has been an ongoing controversy over its effectiveness and sustainability for OA patients. This has decreased the reimbursements given by the government and private insurance companies for treatment over the period of time.
Each of the covered 39 country's color-coded and fully-sourced market models is equipped with epidemiology-based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers the installed base, new sales volumes, product usage, average selling prices, market size, and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Viscosupplementation Devices and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Sanofi , Seikagaku Corp, Bioventus Inc, Anika Therapeutics Inc, Fidia farmaceutici SpA, Ferring Pharmaceuticals AS, Zimmer Biomet Holdings Inc, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -
Not Applicable
Not Applicable
Not Applicable